NCT01948648|UnknownDMC
Effects of Fish Oil and Colesevelam (STAIR7007)
Effects of Fish Oil, Colesevelam and Combination Therapy on Sterol Metabolism in Sitosterolemia
Loading search results
Effects of Fish Oil, Colesevelam and Combination Therapy on Sterol Metabolism in Sitosterolemia
Sponsor study identifier
interventional
13
1 country
1
Study Start
February 6, 2018
Actual (reported)Primary Completion
April 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
If treatment of colesevelam, fish oil in conjunction with ezetimibe, will lead to further reduction in plasma plant sterol levels in sitosterolemia patients. We hypothesize that treatments with fish oil, colesevelam and ezetimibe will maximize decrease in plasma concentrations of sitosterol and other plant sterols in sitosterolemia patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 6, 2013
Actual (reported)September 23, 2013
Actual (reported)February 6, 2018
Actual (reported)April 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Plasma plant sterol level
plasma plant sterol assessment using Gas Chromatography(GC)
32 weeks
Fatty acid
32 weeks
endothelial functions
32 weeks
3.75g/day for 6 weeks
1g/day for 6 weeks
3.75g/day of colesevelam and 1g/day of fish oil for 6 weeks
Drug is in powder form, each packet contains 3.75g of colesevelam hydrochloride. Participant will mixed it with water and have 1 packet per day during the treatment session.
In softgel form, contains 660mg EPA and 330mg DHA. Participant consume 1 softgel per day during treatment session.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Treatment programme
Combination of fish oil and colesevelam
The registry describes a treatment programme. Individual components, doses and actual administration are not established by this entry.
View registry recordRichardson Center for Functional Foods and Nutraceuticals
Winnipeg, Manitoba, Canada
13 participants (actual enrollment reported by the registry).
First Submitted
September 6, 2013
First Posted
September 23, 2013
Study Start
February 6, 2018
Actual (reported)Fish Oil in Total Hip Replacement Randomized Clinical Trial
combination of both colesevelam and fish oil. Participant will consume 1 packet and 1 softgel per day during treatment session.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
April 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 10, 2020
Record last verified: 2019-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: